There is a promising development in the fight against prostate cancer.
Researchers at Oregon Health & Science University's Knight Cancer Institute conducted a double blind study, testing a new drug called Enzalutamide.
Half of the 1,700 patients got the real pill. The other half got a placebo. Results were so impressive that researchers stopped the trial and gave the pill to the placebo group, too.
Read more at KGW.